Certified by Founder Lodge
Amber Bio
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $26,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic med
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 04 ,2023 | Seed | $26,000,000 |
Playground Global
Eli Lilly and Company
Hummingbird Ventures
Pillar VC
RD Fund
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Fabriclore | $1,600,000 | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
K Health | $50,000,000 | (Jul 2, 2024)
Vytal | The reuse system | $6,644,850 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
